Clinical Safety of Extended Interval Dosing of Nivolumab in Patients with Melanoma

Documenti analoghi

• The development of brain metastases in patients with different therapeutic strategies for metastatic renal cell cancer
  di: Sophie H. A. E. Derks, et al.
  Pubblicazione: (2024)
• Using soil samples and footwear to improve forensic palynology: A study about where a soil sample could best be taken along a transect from parking space to dumping site when investigating a crime scene
  di: van Leeuwen
  Pubblicazione: (2022)
• Real‐World Outcomes of Nivolumab and Ipilimumab in Metastatic Melanoma as Third Line and Beyond
  di: Yago Garitaonaindia, et al.
  Pubblicazione: (2026)
• Algorithmic Gatekeeping for Professional Communicators
  di: van Dalen, Arjen
  Pubblicazione: (2023)
• Myocarditis Mimicking Takotsubo Cardiomyopathy With First Dose of Neoadjuvant Nivolumab–Relatlimab
  di: Rohit Rao, et al.
  Pubblicazione: (2025)